flumazenil has been researched along with zolpidem in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (4.04) | 18.7374 |
1990's | 35 (35.35) | 18.2507 |
2000's | 40 (40.40) | 29.6817 |
2010's | 20 (20.20) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lüddens, H; Wieland, HA | 1 |
Cook, JM; Hu, RJ; Liu, R; Skolnick, P; Zhang, P | 1 |
Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
Besnard, F; Costa, B; Greco, G; Lavecchia, A; Marini, AM; Martini, C; Novellino, E; Primofiore, G; Settimo, FD; Taliani, S; Trincavelli, L | 1 |
Besnard, F; Bruni, F; Ciciani, G; Costa, B; Costagli, C; Costanzo, A; Guerrini, G; Malmberg-Aiello, P; Martini, C; Selleri, S | 1 |
Besnard, F; Cosimelli, B; Costa, B; Da Settimo, F; Greco, G; Martini, C; Montali, M; Novellino, E; Primofiore, G; Salerno, S; Taliani, S | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Besnard, F; Cosimelli, B; Da Settimo, F; Ehlardo, M; Greco, G; La Motta, C; Marini, AM; Martini, C; Montali, M; Novellino, E; Primofiore, G; Sala, A; Simorini, F; Taliani, S | 1 |
Besnard, F; Calderone, V; Cosimelli, B; Da Settimo, F; Greco, G; La Motta, C; Marini, AM; Martini, C; Montali, M; Novellino, E; Patrizi, MP; Primofiore, G; Sergianni, V; Simorini, F; Taliani, S | 1 |
Baur, R; Ernst, M; Goeldner, M; Gonthier, A; Sigel, E; Tan, KR | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Czajkowski, C; Hanson, SM; Morlock, EV; Satyshur, KA | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Clayton, T; Cook, JM; Cromer, BA; Ma, C; Majumder, S; Namjoshi, OA; Petrou, S; Platt, DM; Roth, BL; VanLinn, ML; Yin, W | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Choi, Y; Raymer, BK | 1 |
Arbilla, S; Benavides, J; Durand, A; Peny, B; Scatton, B | 1 |
Byrnes, JJ; Greenblatt, DJ; Miller, LG | 1 |
De Luca, C; De Medici, D; Massotti, M | 1 |
Biggio, G; Carcangiu, G; Concas, A; Mereu, G; Passino, N | 1 |
Blanchard, JC; Boireau, A; Doble, A; Dubedat, P; Laduron, PM | 1 |
Askenasi, R; De Witte, O; Debailleul, G; Lheureux, P | 1 |
Danielou, G; Lloyd, GK; Thuret, F | 1 |
Benavides, J; Dubois, A; Morel, E; Peny, B; Perrault, G; Scatton, B; Zivkovic, B | 1 |
Sanger, DJ; Zivkovic, B | 2 |
Sanger, DJ | 1 |
Bottlaender, M; Brouillet, E; Fournier, D; Fuseau, C; Mazière, M; Schmid, L | 1 |
Cohen, C; Sanger, DJ | 1 |
Bannwarth, W; Benke, D; Fritschy, JM; Mohler, H; Trzeciak, A | 1 |
Dubruc, C; Forster, A; Naef, MM; Patat, A; Rosenzweig, P; van Gessel, E | 1 |
Benavides, J; Peny, B; Ruano, D; Scatton, B; Vitorica, J | 1 |
Auta, J; Costa, E; Guidotti, A; Kozikowski, A; Ma, D; Romeo, E | 1 |
Gage, TW | 1 |
Balkin, TJ; Belenky, GL; Davis, HQ; Wesensten, NJ | 1 |
Meier-Abt, PJ; Radovanovic, D; Wyss, PA | 1 |
Hadingham, KL; Palmer, KJ; Thompson, SA; Wafford, KA; Whiting, PJ | 1 |
Blanc, P; Carbajal, R; Hoenn, E; Lenclen, R; Olivier-Martin, M; Paupe, A; Simon, N | 1 |
Araujo, F; Benavides, J; Ruano, D; Schoemaker, H; Tan, S; Vitorica, J | 1 |
Abadie, P; Baron, JC; Barré, L; Patat, A; Rioux, P; Scatton, B; Zarifian, E | 1 |
Baur, R; Buhr, A; Sigel, E | 1 |
Aks, S; Burda, T; Fischbein, C; Leikin, JB; Woods, K | 1 |
Benke, D; Fritschy, JM; Johnson, DK; Mohler, H; Rudolph, U | 1 |
Ator, NA; Grech, DM; Griffiths, RR; Weerts, EM | 1 |
Atack, JR; McKernan, RM; Smith, AJ | 1 |
Griffiths, RR; Weerts, EM | 1 |
Burton, JH; Dorfman, T; Lyon, L; Tomassoni, AJ | 1 |
Leeuwin, RS; van Wilgenburg, H; Zeegers, A | 1 |
Atack, JR; Emms, F; McKernan, RM; Smith, AJ | 1 |
Araujo, F; Ruano, D; Vitorica, J | 1 |
Avenet, P; Granger, P; Griebel, G; Letang, V; Perrault, G; Sanger, DJ; Schoemaker, H | 1 |
Chen, S; Kometiani, P; Lilly, SM; Rosenberg, HC; Tietz, EI; Zeng, XJ | 1 |
Lelas, S; Rowlett, JK; Spealman, RD | 1 |
Bannister, AP; Hughes, DI; Pawelzik, H; Thomson, AM | 1 |
Atack, JR; Chadha, A; Duty, S; Howell, O; Sur, C | 1 |
Firestone, LL; Homanics, GE; Quinlan, JJ | 1 |
Ansaldo, MA; Fedele, E; Raiteri, M; Varnier, G | 1 |
Betti, L; Bistocchi, M; Giannaccini, G; Gori, M; Lucacchini, A | 1 |
Cook, JM; Ma, C; Miczek, KA; Rowlett, JK; Tornatzky, W | 1 |
Bromidge, FA; Casula, MA; Hadingham, KL; Martin, K; Maubach, K; Pillai, GV; Seabrook, GR; Whiting, PJ; Wingrove, PB | 1 |
Bergman, J; Cook, JM; Cox, ED; Paronis, CA | 1 |
Carter, L; Cook, JM; France, CP; Gerak, LR; Ma, C; McMahon, LR | 1 |
Safo, P; Thompson, SA; Wafford, KA; Wheat, L; Whiting, PJ; Wingrove, PB | 1 |
Copolov, D; Dean, B; McLeod, M; Pralong, D | 1 |
Cook, J; Ma, C; Platt, DM; Rowlett, JK; Spealman, RD | 1 |
Clauss, RP; Dormehl, IC; Kilian, E; Louw, WK; Nel, WH; Oliver, DW | 1 |
Haga, C | 1 |
Chen, L; Savio Chan, C; Yung, WH | 1 |
Foster, AC; Grigoriadis, DE; Gross, RS; Petroski, RE; Sullivan, SK; Verge, G | 1 |
Bokonjić, DR; Cook, JM; Obradović, DI; Savić, MM; Ugresić, ND; Yin, W | 1 |
Bokonjić, DR; Cook, JM; Obradović, DI; Sarma, PV; Savić, MM; Ugresić, ND | 1 |
Dean, B; McLeod, M; Scarr, E | 1 |
Fornasiero, A; Gerra, G; Lechi, A; Lugoboni, F; Mezzelani, P; Quaglio, G | 1 |
Cook, JM; Duke, AN; Huang, S; Mattingly, BA; Platt, DM; Rowlett, JK; Yin, W | 1 |
Besheer, J; Hodge, CW; Lepoutre, V; Mole, B | 1 |
Groenink, L; Olivier, B; Oosting, R; Toth, M; Van Bogaert, M; van Oorschot, R | 1 |
Chen, L; Fung, KS; Xie, JX; Yung, WH | 1 |
Capasso, A; Cavallo, F; Raffa, RB | 1 |
Heikkinen, AE; Korpi, ER; Möykkynen, TP | 1 |
Bittencourt, PL; Cavalcanti, AR; da Silva, VC; Pinho, S; Zollinger, CC | 1 |
Allen, MS; Brian Nofsinger, J; Hopkins, SC; Koch, P; Varney, MA | 1 |
Atack, JR; Cook, JM; Dawson, GR; Licata, SC; Platt, DM; Rowlett, JK; Rüedi-Bettschen, D; Van Linn, ML | 1 |
Hellsten, KS; Hyde, TM; Kleinman, JE; Korpi, ER; Maksimow, A; Särkioja, T; Sinkkonen, ST; Uusi-Oukari, M | 1 |
Czopowicz, M; Frymus, T; Szalus-Jordanow, O | 1 |
Cook, JM; Divljaković, J; Milić, M; Rallapalli, S; Savić, MM; Timić, T; van Linn, ML | 1 |
Casari, R; Faccini, M; Licata, M; Lugoboni, F; Mathewson, S; Quaglio, G; Vigneau, CV | 1 |
Cook, JM; Groenink, L; Hansen, HH; Mirza, NR; Nielsen, EØ; Olivier, B; van Oorschot, R; Vinkers, CH | 1 |
Cook, JM; Fischer, BD; Namjoshi, OA; Rowlett, JK; Teixeira, LP; van Linn, ML | 1 |
Gunja, N | 1 |
Cho, S; Han, D; Jin, YH; Jin, Z; Kim, IH; Kim, S | 1 |
Bienkowski, P; Kolaczkowski, M; Korkosz, A; Kostowski, W; Mierzejewski, P; Nowak, N; Samochowiec, J; Scinska, A; Sienkiewicz-Jarosz, H | 1 |
Carstairs, SD; Negus, E; Thornton, SL | 1 |
Hall, SD; Jones, RS; Ladds, G; Prokic, EJ; Stanford, IM; Weston, C; Woodhall, GL; Yamawaki, N | 1 |
Cho, NC; Cho, S; Kim, J; Lee, CJ; Pae, AN; Park, KD; Um, MY; Woo, J; Yang, H; Yoon, M | 1 |
3 review(s) available for flumazenil and zolpidem
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
The clinical and forensic toxicology of Z-drugs.
Topics: Acetamides; Azabicyclo Compounds; Coma; Drug Overdose; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Humans; Hypnotics and Sedatives; Piperazines; Pyridines; Pyrimidines; Zolpidem | 2013 |
3 trial(s) available for flumazenil and zolpidem
Article | Year |
---|---|
Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Double-Blind Method; Flumazenil; Humans; Hypnotics and Sedatives; Male; Memory; Psychomotor Performance; Pyridines; Zolpidem | 1994 |
Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
Topics: Administration, Oral; Adolescent; Adult; Flumazenil; Humans; Hypnotics and Sedatives; Male; Memory; Placebo Effect; Pyridines; Time Factors; Triazolam; Volunteers; Zolpidem | 1995 |
Emergency department use of flumazenil prior to poison center consultation.
Topics: Antidotes; Benzodiazepines; Contraindications; Drug Overdose; Flumazenil; Humans; Hypnotics and Sedatives; Poison Control Centers; Pyridines; Treatment Outcome; Zolpidem | 1997 |
93 other study(ies) available for flumazenil and zolpidem
Article | Year |
---|---|
Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor.
Topics: Amino Acid Sequence; Azides; Base Sequence; Benzodiazepines; Binding Sites; Diazepam; GABA Agonists; Humans; Molecular Sequence Data; Mutation; Receptors, GABA-A; Structure-Activity Relationship | 1994 |
Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors.
Topics: Animals; Benzodiazepines; Cerebellum; Flunitrazepam; Hippocampus; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Mass Spectrometry; Mice; Molecular Probes; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Structure-Activity Relationship | 1996 |
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
Topics: Amides; Animals; Brain; Cattle; Glyoxylates; In Vitro Techniques; Indoles; Ligands; Models, Molecular; Radioligand Assay; Receptors, GABA-A; Structure-Activity Relationship | 2001 |
Benzodiazepine receptor ligands. 7. Synthesis and pharmacological evaluation of new 3-esters of the 8-chloropyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide. 3-(2-Thienylmethoxycarbonyl) derivative: an anxioselective agent in rodents.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Avoidance Learning; Cell Line; Cerebral Cortex; Cyclic N-Oxides; Drug Interactions; Ethanol; Exploratory Behavior; GABA Agents; Heterocyclic Compounds, 3-Ring; Humans; In Vitro Techniques; Ligands; Memory; Mice; Motor Skills; Neuromuscular Agents; Rats; Receptors, GABA-A; Seizures; Sleep; Structure-Activity Relationship; Triazines | 2002 |
High affinity central benzodiazepine receptor ligands: synthesis and biological evaluation of a series of phenyltriazolobenzotriazindione derivatives.
Topics: Animals; Binding, Competitive; Brain; Cattle; Cell Line; Chlorides; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; In Vitro Techniques; Models, Molecular; Protein Isoforms; Radioligand Assay; Rats; Recombinant Proteins; Structure-Activity Relationship; Triazines; Triazoles | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamides.
Topics: Amides; Animals; Binding Sites; Binding, Competitive; Cell Line; GABA-A Receptor Antagonists; Humans; Hydrogen Bonding; Indoles; Ligands; Molecular Structure; Rats; Stereoisomerism; Structure-Activity Relationship | 2006 |
Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Topics: Amides; Animals; Cattle; Cell Line; Cerebral Cortex; GABA-A Receptor Agonists; Glyoxylates; Hypnotics and Sedatives; In Vitro Techniques; Indoles; Ligands; Male; Mice; Mice, Inbred BALB C; Molecular Conformation; Motor Activity; Radioligand Assay; Rats; Structure-Activity Relationship | 2007 |
Proximity-accelerated chemical coupling reaction in the benzodiazepine-binding site of gamma-aminobutyric acid type A receptors: superposition of different allosteric modulators.
Topics: Allosteric Regulation; Allosteric Site; Amino Acid Substitution; Benzodiazepines; Central Nervous System Agents; Cysteine; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; Ligands; Models, Molecular; Mutation, Missense; Protein Isoforms; Receptors, GABA-A; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different.
Topics: Azabicyclo Compounds; Benzodiazepines; Binding Sites; Cell Line; Computer Simulation; Cysteine; DNA Mutational Analysis; Eszopiclone; GABA-A Receptor Agonists; Humans; Hydrogen Bonding; Ligands; Models, Chemical; Models, Molecular; Mutagenesis, Site-Directed; Piperazines; Pyridines; Receptors, GABA-A; Structure-Activity Relationship; Zolpidem | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Topics: Alcoholism; Animals; Benzodiazepines; Binding Sites; Carbolines; Cell Line; Computer Simulation; GABA-A Receptor Antagonists; Humans; Protein Subunits; Rats; Receptors, GABA-A; Stereoisomerism; Structure-Activity Relationship | 2010 |
Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.
Topics: Animals; Benzodiazepines; Binding Sites; Binding, Competitive; Brain Chemistry; Cell Membrane; Central Nervous System; Flumazenil; Hypnotics and Sedatives; Pyridazines; Pyridines; Rats; Receptors, GABA-A; Triazolam; Zolpidem | 1992 |
Benzodiazepine receptor binding of nonbenzodiazepines in vivo: alpidem, zolpidem and zopiclone.
Topics: Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Brain; Cerebellum; Cerebral Cortex; Dose-Response Relationship, Drug; Flumazenil; Hippocampus; Hypnotics and Sedatives; Imidazoles; Male; Mice; Mice, Inbred Strains; Piperazines; Pyridines; Receptors, GABA-A; Reference Values; Zolpidem | 1992 |
Relative efficacies of benzodiazepine receptor agonists in affecting red nucleus electrical activity in rabbits.
Topics: Animals; Bicuculline; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Flumazenil; Flunitrazepam; Imidazoles; Isoquinolines; Male; Pentylenetetrazole; Pyridazines; Pyridines; Rabbits; Receptors, GABA-A; Red Nucleus; Zolpidem | 1990 |
Reduction of reticulata neuronal activity by zolpidem and alpidem, two imidazopyridines with high affinity for type I benzodiazepine receptors.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Diazepam; Flumazenil; Hypnotics and Sedatives; Imidazoles; Male; Neurons; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reticular Formation; Zolpidem | 1990 |
Preferential decrease in dopamine utilization in prefrontal cortex by zopiclone, diazepam and zolpidem in unstressed rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Azabicyclo Compounds; Cerebral Cortex; Corpus Striatum; Diazepam; Dopamine; Flumazenil; Male; Piperazines; Pyridines; Rats; Rats, Inbred Strains; Stress, Physiological; Zolpidem | 1990 |
Zolpidem intoxication mimicking narcotic overdose: response to flumazenil.
Topics: Adult; Antidotes; Coma; Ethanol; Flumazenil; Humans; Hypnotics and Sedatives; Male; Narcotics; Pyridines; Zolpidem | 1990 |
The activity of zolpidem and other hypnotics within the gamma-aminobutyric acid (GABAA) receptor supramolecular complex, as determined by 35S-t-butylbicyclophosphorothionate (35S-TBPS) binding to rat cerebral cortex membranes.
Topics: Animals; Bicuculline; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Hypnotics and Sedatives; In Vitro Techniques; Male; Pyridines; Rats; Rats, Inbred Strains; Receptors, GABA-A; Zolpidem | 1990 |
In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.
Topics: Animals; Autoradiography; Binding Sites; Brain; Flumazenil; Flunitrazepam; Hypnotics and Sedatives; In Vitro Techniques; Male; Mice; Pyridazines; Pyridines; Receptors, GABA-A; Zolpidem | 1988 |
The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Flumazenil; Generalization, Psychological; Hypnotics and Sedatives; Male; Pyridines; Rats; Rats, Inbred Strains; Zolpidem | 1986 |
Investigation of the actions of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 using the schedule-controlled behavior of rats.
Topics: Animals; Anxiety; Behavior, Animal; Benzodiazepines; Diazepam; Drug Interactions; Flumazenil; Male; Pyrazoles; Pyridines; Rats; Rats, Inbred Strains; Zolpidem | 1986 |
Further behavioural evidence for the selective sedative action of zolpidem.
Topics: Animals; Chlordiazepoxide; Conditioning, Operant; Eating; Exploratory Behavior; Flumazenil; Hypnotics and Sedatives; Male; Punishment; Pyridines; Rats; Rats, Inbred Strains; Zolpidem | 1988 |
Zolpidem displays heterogeneity in its binding to the nonhuman primate benzodiazepine receptor in vivo.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Flumazenil; Male; Papio; Pyridines; Receptors, GABA-A; Tissue Distribution; Zolpidem | 1995 |
Effects of chronic treatment with triazolam on operant responding in rats.
Topics: Animals; Conditioning, Operant; Drug Tolerance; Flumazenil; Hypnotics and Sedatives; Male; Pyridines; Rats; Rats, Wistar; Reinforcement Schedule; Time Factors; Triazolam; Zolpidem | 1994 |
Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant.
Topics: Animals; Brain Chemistry; Carbolines; Flumazenil; Flunitrazepam; Genetic Variation; Immunohistochemistry; Male; Microscopy, Confocal; Molecular Weight; Precipitin Tests; Protein Conformation; Pyridazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Tissue Distribution; Zolpidem | 1994 |
Comparative autoradiographic distribution of central omega (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Autoradiography; Binding, Competitive; Brain; Flumazenil; Hypnotics and Sedatives; Imidazoles; Kinetics; Male; Organ Specificity; Pyridazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Spinal Cord; Tritium; Zolpidem | 1993 |
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.
Topics: Aggression; Allosteric Regulation; Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Clonazepam; Desoxycorticosterone; Flumazenil; Imidazoles; Indoleacetic Acids; Isoniazid; Isoquinolines; Mitochondria; Phobic Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, GABA-A; Seizures; Zolpidem | 1993 |
New drugs from 1991-1992.
Topics: 1-Naphthylamine; Anti-Bacterial Agents; Anti-Infective Agents; Anticholesteremic Agents; Antineoplastic Agents; Antiviral Agents; Azithromycin; Butanones; Cardiovascular Agents; Clarithromycin; Drug Approval; Drug Combinations; Drug Interactions; Enoxacin; Finasteride; Flumazenil; Fluoroquinolones; Humans; Ketorolac Tromethamine; Lactams; Nabumetone; Pyridines; Quinolones; Sertraline; Tolmetin; Tromethamine; United States; United States Food and Drug Administration; Zolpidem | 1993 |
[Acute overdose of Zolpidem (Stilnox)].
Topics: Adolescent; Adult; Aged; Antidotes; Coma; Drug Overdose; Female; Flumazenil; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Pyridines; Retrospective Studies; Triazolam; Zolpidem | 1996 |
Expression and pharmacology of human GABAA receptors containing gamma 3 subunits.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Base Sequence; Benzodiazepines; Benzodiazepinones; Carbolines; Flumazenil; Flunitrazepam; GABA Modulators; Humans; Molecular Sequence Data; Pyrazoles; Pyridazines; Pyridines; Receptors, GABA-A; Recombinant Proteins; Sequence Homology, Amino Acid; Triazolam; Xenopus; Zolpidem | 1995 |
[Flumazenil in zolpidem poisoning in children].
Topics: Antidotes; Child, Preschool; Female; Flumazenil; Humans; Hypnotics and Sedatives; Male; Pyridines; Zolpidem | 1996 |
Molecular and pharmacological characterization of native cortical gamma-aminobutyric acidA receptors containing both alpha1 and alpha3 subunits.
Topics: Amino Acid Sequence; Animals; Anti-Anxiety Agents; Antibodies; Binding Sites; Cattle; Cell Membrane; Cerebral Cortex; Chromatography, Affinity; Flumazenil; Hypnotics and Sedatives; Immunoblotting; Kinetics; Macromolecular Substances; Models, Structural; Peptide Fragments; Pyridazines; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 1996 |
Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography.
Topics: Adult; Brain; Flumazenil; Humans; Male; Pyridines; Radioligand Assay; Receptors, GABA-A; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Zolpidem | 1996 |
Subtle changes in residue 77 of the gamma subunit of alpha1beta2gamma2 GABAA receptors drastically alter the affinity for ligands of the benzodiazepine binding site.
Topics: Animals; Benzodiazepines; Binding Sites; Cell Line; Diazepam; Female; Flumazenil; Humans; Kinetics; Macromolecular Substances; Mutagenesis, Site-Directed; Oocytes; Phenylalanine; Point Mutation; Pyridines; Radioligand Assay; Rats; Receptors, GABA-A; Recombinant Proteins; Transfection; Xenopus laevis; Zolpidem | 1997 |
GABAA-receptor alpha-subunit is an essential prerequisite for receptor formation in vivo.
Topics: Animals; Autoradiography; Brain Chemistry; Chromosome Deletion; Flumazenil; GABA Modulators; Hypnotics and Sedatives; Immunohistochemistry; Kinetics; Membranes; Mice; Mutation; Pyridines; Radioligand Assay; Receptors, GABA-A; Zolpidem | 1997 |
Zolpidem physical dependence assessed across increasing doses under a once-daily dosing regimen in baboons.
Topics: Animals; Behavior, Animal; Flumazenil; GABA Modulators; Hypnotics and Sedatives; Male; Papio; Pyridines; Substance Withdrawal Syndrome; Zolpidem | 1998 |
Benzodiazepine modulation of recombinant alpha1beta3gamma2 GABA(A) receptor function efficacy determination using the Cytosensor microphysiometer.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Biosensing Techniques; Cell Count; Cells, Cultured; Dose-Response Relationship, Drug; Eukaryotic Cells; Flumazenil; Flunitrazepam; GABA Modulators; gamma-Aminobutyric Acid; Humans; Pyridines; Receptors, GABA-A; Recombinant Proteins; Time Factors; Zolpidem | 1998 |
Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons.
Topics: Animals; Behavior, Animal; Body Weight; Flumazenil; Food; GABA Modulators; Hypnotics and Sedatives; Injections, Intravenous; Male; Papio; Pyridines; Self Administration; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 1998 |
Continuous flumazenil infusion in the treatment of zolpidem (Ambien) and ethanol coingestion.
Topics: Antidotes; Depressive Disorder; Ethanol; Female; Flumazenil; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Middle Aged; Poisoning; Pyridines; Suicide, Attempted; Zolpidem | 1998 |
Cardiac effects of benzodiazepine receptor agonists and antagonists in the isolated rat heart: a comparative study.
Topics: Animals; Benzodiazepines; Cardiac Output; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Heart; In Vitro Techniques; Isoquinolines; Myocardial Contraction; Perfusion; Pyridines; Rats; Receptors, GABA-A; Zolpidem | 1998 |
Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors.
Topics: Animals; Benzodiazepines; Binding Sites; Cerebellum; Flumazenil; GABA Modulators; GABA-A Receptor Antagonists; In Vitro Techniques; Ligands; Male; Mice; Pyridazines; Pyridines; Receptors, GABA-A; Spinal Cord; Time Factors; Tritium; Zolpidem | 1999 |
Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding Sites; Chromatography, Affinity; Flumazenil; GABA Modulators; Hippocampus; Hypnotics and Sedatives; Macromolecular Substances; Precipitin Tests; Pyridazines; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Tritium; Zolpidem | 1999 |
New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepines; Binding, Competitive; Carbolines; Diazepam; Flumazenil; GABA Antagonists; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Ligands; Male; Mice; Mice, Inbred BALB C; Motor Activity; Muscle Relaxants, Central; Patch-Clamp Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 1999 |
Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Autoradiography; Behavior, Animal; Benzodiazepines; Convulsants; Drug Tolerance; Electrophysiology; Flumazenil; Flurazepam; GABA Modulators; GABA-A Receptor Antagonists; Hippocampus; Hypnotics and Sedatives; Immunohistochemistry; Male; Patch-Clamp Techniques; Pentylenetetrazole; Pyridines; Rats; Rats, Sprague-Dawley; Seizures; Zolpidem | 1999 |
Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
Topics: Animals; Benzodiazepines; Discrimination, Psychological; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Midazolam; Pyridines; Saimiri; Zolpidem | 1999 |
Differential sensitivity to Zolpidem of IPSPs activated by morphologically identified CA1 interneurons in slices of rat hippocampus.
Topics: Animals; Diazepam; Evoked Potentials; Flumazenil; GABA Agonists; GABA Modulators; Hippocampus; Interneurons; Male; Presynaptic Terminals; Pyramidal Cells; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2000 |
Changes in [3H]zolpidem and [3H]Ro 15-1788 binding in rat globus pallidus and substantia nigra pars reticulata following a nigrostriatal tract lesion.
Topics: Animals; Autoradiography; Flumazenil; GABA Agonists; GABA Modulators; Globus Pallidus; Male; Nerve Degeneration; Pyridines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Substantia Nigra; Tritium; Zolpidem | 2000 |
Mice lacking the long splice variant of the gamma 2 subunit of the GABA(A) receptor are more sensitive to benzodiazepines.
Topics: Alternative Splicing; Animals; Azides; Benzodiazepines; Brain; Carbolines; Diazepam; Drug Resistance; Female; Flumazenil; GABA Modulators; Genetic Variation; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Midazolam; Pyridines; Receptors, GABA-A; Sleep; Zolpidem | 2000 |
Benzodiazepine-sensitive GABA(A) receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats.
Topics: Animals; Anti-Anxiety Agents; Bicuculline; Cerebellum; Cyclic GMP; Diazepam; Flumazenil; Infusions, Parenteral; Kinetics; Male; Microdialysis; Muscimol; N-Methylaspartate; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2000 |
[3H]Ro 15-1788 binding sites to brain membrane of the saltwater Mugil cephalus.
Topics: Animals; Binding Sites; Binding, Competitive; Brain; Carbolines; Cell Membrane; Chlorides; Diazepam; Female; Fishes; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Imidazoles; Ionophores; Male; Pyridines; Receptors, GABA-A; Synaptosomes; Tritium; Zolpidem | 2001 |
Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-Carboline-3-carboxylate-t-butyl ester (beta-CCt).
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Body Temperature; Carbolines; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Antagonists; Mice; Pyridines; Receptors, GABA-A; Triazolam; Vocalization, Animal; Zolpidem | 2001 |
Identification of amino acid residues responsible for the alpha5 subunit binding selectivity of L-655,708, a benzodiazepine binding site ligand at the GABA(A) receptor.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Anti-Anxiety Agents; Azides; Benzodiazepines; Binding Sites; Binding, Competitive; Carbolines; DNA, Complementary; Female; Flumazenil; Flunitrazepam; GABA-A Receptor Agonists; Humans; Imidazoles; Isoleucine; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Oocytes; Protein Binding; Protein Structure, Tertiary; Protein Subunits; Pyridazines; Pyridines; Receptors, GABA-A; Recombinant Fusion Proteins; Sequence Alignment; Structure-Activity Relationship; Threonine; Transfection; Xenopus laevis; Zolpidem | 2001 |
Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem, and midazolam in squirrel monkeys.
Topics: Acetamides; Animals; Carbolines; Dose-Response Relationship, Drug; Flumazenil; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; Hypnotics and Sedatives; Male; Midazolam; Pyridines; Pyrimidines; Reaction Time; Receptors, GABA-A; Saimiri; Zolpidem | 2001 |
Discriminative stimulus effects of benzodiazepine (BZ)(1) receptor-selective ligands in rhesus monkeys.
Topics: Acetamides; Animals; Carbolines; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Flumazenil; GABA Agonists; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Ligands; Macaca mulatta; Midazolam; Pyridines; Pyrimidines; Receptors, GABA-A; Zolpidem | 2002 |
Mechanism of alpha-subunit selectivity of benzodiazepine pharmacology at gamma-aminobutyric acid type A receptors.
Topics: Animals; Anti-Anxiety Agents; Binding, Competitive; Cell Line; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; Flunitrazepam; gamma-Aminobutyric Acid; Humans; Membrane Potentials; Mutation; Oocytes; Protein Subunits; Pyridazines; Pyridines; Radioligand Assay; Receptors, GABA-A; Tritium; Xenopus laevis; Zolpidem | 2002 |
The heterogeneity of central benzodiazepine receptor subtypes in the human hippocampal formation, frontal cortex and cerebellum using [3H]flumazenil and zolpidem.
Topics: Cerebellum; Clonazepam; Flumazenil; Frontal Lobe; GABA Agents; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Humans; Male; Middle Aged; Neurons; Protein Binding; Pyridines; Radioligand Assay; Receptors, GABA-A; Synaptic Transmission; Tritium; Zolpidem | 2002 |
Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Topics: Animals; Ataxia; Benzodiazepines; Carbolines; Dose-Response Relationship, Drug; Drug Interactions; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Antagonists; Male; Motor Activity; Pyridines; Receptors, GABA-A; Saimiri; Social Behavior; Triazolam; Zolpidem | 2002 |
Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.
Topics: Algorithms; Animals; Brain; Cerebrovascular Circulation; Flumazenil; GABA Modulators; Hypnotics and Sedatives; Male; Nervous System Diseases; Papio; Pyridines; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Zolpidem | 2002 |
[Poisonings with benzodiazepine-like drugs].
Topics: Acetamides; Antidotes; Azabicyclo Compounds; Flumazenil; Humans; Hypnotics and Sedatives; Norway; Piperazines; Poisoning; Pyridines; Pyrimidines; Zolpidem | 2003 |
Electrophysiological and behavioral effects of zolpidem in rat globus pallidus.
Topics: Action Potentials; Animals; Animals, Newborn; Behavior, Animal; Drug Interactions; Electrophysiology; Flumazenil; GABA Agonists; GABA Modulators; Globus Pallidus; In Vitro Techniques; Motor Activity; Patch-Clamp Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Synapses; Zolpidem | 2004 |
Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor.
Topics: Acetamides; Animals; Azides; Benzodiazepines; Binding Sites; Brain; Cell Membrane; Cerebellum; Cerebral Cortex; Chloride Channels; Flumazenil; GABA Modulators; gamma-Aminobutyric Acid; Kinetics; Male; Pyridines; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Thiophenes; Triazolam; Tritium; Zolpidem | 2004 |
Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding Sites; Carbolines; Drug Interactions; Flumazenil; GABA Modulators; Ligands; Male; Maze Learning; Mice; Midazolam; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 2004 |
Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepines; Binding Sites; Carbolines; Convulsants; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Habituation, Psychophysiologic; Injections, Intraperitoneal; Ligands; Male; Midazolam; Motor Activity; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Retention, Psychology; Zolpidem | 2005 |
Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
Topics: Adult; Aged; Binding, Competitive; Bipolar Disorder; Brain Chemistry; Clonazepam; Female; Flumazenil; GABA Agonists; GABA Modulators; gamma-Aminobutyric Acid; Hippocampus; Humans; Male; Middle Aged; Muscimol; Protein Subunits; Pyridines; Radioligand Assay; Receptors, GABA-A; Schizophrenia; Zolpidem | 2005 |
Dependence on zolpidem: two case reports of detoxification with flumazenil infusion.
Topics: Adult; Antidotes; Flumazenil; Half-Life; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Male; Pyridines; Substance-Related Disorders; Zolpidem | 2005 |
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes.
Topics: Alprazolam; Animals; Benzodiazepines; Diazepam; Flumazenil; Male; Pyridines; Receptors, GABA-A; Saimiri; Sucrose; Zolpidem | 2006 |
GABAA receptor regulation of voluntary ethanol drinking requires PKCepsilon.
Topics: Alcohol Drinking; Animals; Diazepam; Flumazenil; GABA Agonists; GABA Modulators; Hypnotics and Sedatives; Mice; Mice, Knockout; Motor Activity; Protein Kinase C-epsilon; Pyridines; Receptors, GABA-A; Zolpidem | 2006 |
Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs.
Topics: Animals; Body Temperature; Body Temperature Regulation; Buspirone; Diazepam; Fever; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Modulators; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyridines; Receptor, Serotonin, 5-HT1A; Receptors, GABA-A; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Stress, Psychological; Triazoles; Zolpidem | 2006 |
Zolpidem modulates GABA(A) receptor function in subthalamic nucleus.
Topics: Animals; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Motor Activity; Neural Inhibition; Neural Pathways; Neurons; Organ Culture Techniques; Parkinson Disease; Patch-Clamp Techniques; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, GABA-A; Subthalamic Nucleus; Synaptic Transmission; Time Factors; Zolpidem | 2007 |
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2007 |
Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists.
Topics: Animals; Benzodiazepines; Diazepam; Dizocilpine Maleate; Ethanol; Excitatory Postsynaptic Potentials; Female; Flumazenil; GABA-A Receptor Agonists; Glutamic Acid; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Morphine; Neurons; Patch-Clamp Techniques; Pyridines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Ventral Tegmental Area; Zolpidem | 2009 |
Delayed-onset hepatic encephalopathy induced by zolpidem: a case report.
Topics: Aged; Delayed-Action Preparations; Female; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Pyridines; Zolpidem | 2008 |
In vivo saturation binding of GABA-A receptor ligands to estimate receptor occupancy using liquid chromatography/tandem mass spectrometry.
Topics: Algorithms; Animals; Azabicyclo Compounds; Binding Sites; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Modulators; Hypnotics and Sedatives; In Vitro Techniques; Indicators and Reagents; Ligands; Male; Mice; Models, Statistical; Piperazines; Pyridines; Receptors, GABA-A; Stereoisomerism; Tandem Mass Spectrometry; Triazoles; Zolpidem | 2009 |
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.
Topics: Animals; Barbiturates; Carbolines; Catheterization; Central Nervous System Depressants; Diazepam; Discrimination, Psychological; Dose-Response Relationship, Drug; Ethanol; Flumazenil; Fluorobenzenes; GABA Agonists; GABA Antagonists; GABA Modulators; Neuropsychological Tests; Pyridines; Receptors, GABA-A; Saimiri; Triazoles; Zolpidem | 2010 |
Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding.
Topics: Adult; Autoradiography; Azides; Benzodiazepines; Female; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Humans; Locus Coeruleus; Male; Melanins; Neurons; Pyridines; Radioligand Assay; Receptors, GABA-A; Tyrosine 3-Monooxygenase; Zolpidem | 2010 |
Zolpidem poisoning in a cat.
Topics: Animals; Antidotes; Ataxia; Cat Diseases; Cats; Flumazenil; Hyperkinesis; Hypnotics and Sedatives; Male; Pyridines; Zolpidem | 2010 |
The role of α1 and α5 subunit-containing GABAA receptors in motor impairment induced by benzodiazepines in rats.
Topics: Animals; Ataxia; Benzodiazepines; Benzodiazepinones; Carbolines; Diazepam; Flumazenil; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; Hand Strength; Imidazoles; Male; Muscle Relaxation; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Rotarod Performance Test; Zolpidem | 2012 |
Megadose bromazepam and zolpidem dependence: two case reports of treatment with flumazenil and valproate.
Topics: Adult; Anticonvulsants; Bromazepam; Female; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; Humans; Pyridines; Substance-Related Disorders; Valproic Acid; Zolpidem | 2012 |
GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Benzodiazepinones; Body Temperature; Brain; Diazepam; DNA Primers; Drug Tolerance; Flumazenil; Hypnotics and Sedatives; In Situ Hybridization; Male; Mice; Mice, Mutant Strains; Pyridazines; Pyridines; Receptors, GABA-A; Triazoles; Zolpidem | 2012 |
Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation.
Topics: Animals; Benzodiazepines; Chlordiazepoxide; Conditioning, Operant; Dose-Response Relationship, Drug; Flumazenil; Food; GABA Antagonists; GABA Modulators; Imidazoles; Pyridines; Receptors, GABA-A; Reinforcement Schedule; Saimiri; Substance-Related Disorders; Time Factors; Zolpidem | 2013 |
Potentiating effect of glabridin on GABAA receptor-mediated responses in dorsal raphe neurons.
Topics: Animals; Anti-Anxiety Agents; Brain; Diazepam; Dose-Response Relationship, Drug; Flumazenil; GABA Agents; gamma-Aminobutyric Acid; Glycyrrhiza; Hypnotics and Sedatives; Isoflavones; Neurons; Pentobarbital; Phenols; Plant Extracts; Plant Roots; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Zolpidem | 2013 |
Pharmacological characteristics of zolpidem-induced catalepsy in the rat.
Topics: Animals; Catalepsy; Dizocilpine Maleate; Dose-Response Relationship, Drug; Flumazenil; GABA-A Receptor Antagonists; Hypnotics and Sedatives; Male; Naltrexone; Narcotic Antagonists; Pyridines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Time Factors; Zolpidem | 2013 |
Pediatric zolpidem ingestion demonstrating zero-order kinetics treated with flumazenil.
Topics: Antidotes; Central Nervous System Depressants; Child; Coma; Down Syndrome; Drug Overdose; Emergencies; Flumazenil; Half-Life; Humans; Hypnotics and Sedatives; Male; Molecular Structure; Poisoning; Pyridines; Zolpidem | 2013 |
Cortical oscillatory dynamics and benzodiazepine-site modulation of tonic inhibition in fast spiking interneurons.
Topics: Action Potentials; Animals; Beta Rhythm; Dose-Response Relationship, Drug; Flumazenil; GABA Modulators; GABA-A Receptor Agonists; gamma-Aminobutyric Acid; Inhibitory Postsynaptic Potentials; Interneurons; Kinetics; Male; Models, Neurological; Patch-Clamp Techniques; Pyramidal Cells; Pyridines; Rats, Wistar; Receptors, GABA-A; Tissue Culture Techniques; Zolpidem | 2015 |
α-Pinene, a Major Constituent of Pine Tree Oils, Enhances Non-Rapid Eye Movement Sleep in Mice through GABAA-benzodiazepine Receptors.
Topics: Animals; Benzodiazepines; Bicyclic Monoterpenes; Binding Sites; Eye Movements; Flumazenil; Inhibitory Postsynaptic Potentials; Male; Mice, Inbred C57BL; Mice, Inbred ICR; Models, Molecular; Monoterpenes; Pentobarbital; Pinus; Plant Oils; Pyridines; Receptors, GABA-A; Sleep; Sleep, REM; Time Factors; Wakefulness; Zolpidem | 2016 |